Etripamil Nasal Spray in Patients With Paroxysmal Supraventricular Tachycardia
Clinical trial NCT04952610 · COMPLETED
Trial details
- NCT number
- NCT04952610
- Sponsor
- Milestone Pharmaceuticals Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-13
- Primary completion
- 2026-04-10
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.